POTASSIUM CHLORIDE EXTENDED-RELEASE

POTASSIUM CHLORIDE EXTENDED-RELEASE was reported 93874 times

POTASSIUM CHLORIDE EXTENDED-RELEASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 184 0.6073
1 APPENDICOLITH 211 0.5452
2 SLEEP DISORDER THERAPY 103 0.5202
3 ANALGESIC THERAPY 100 0.3115
4 DRUG THERAPY 93 0.2743
5 DEVICE MAINTENANCE ISSUE 86 0.1463
6 FEMALE GENITAL TRACT FISTULA 200 0.1170
7 RADICULOPATHY 243 0.0921
8 HYPERPHOSPHATAEMIA 174 0.0809
9 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 79 0.0744
10 INFUSION SITE DISCHARGE 130 0.0741
11 PROCTITIS 199 0.0710
12 CHRONIC SINUSITIS 262 0.0697
13 CARDIOACTIVE DRUG LEVEL INCREASED 91 0.0692
14 LEFT ATRIAL DILATATION 83 0.0650
15 OESOPHAGEAL SPASM 119 0.0645
16 BLOOD PHOSPHORUS INCREASED 176 0.0644
17 HYPERPARATHYROIDISM SECONDARY 151 0.0602
18 INFUSION SITE INFECTION 138 0.0593
19 METABOLIC ALKALOSIS 92 0.0573
20 NEPHROGENIC ANAEMIA 262 0.0565
21 ESSENTIAL HYPERTENSION 102 0.0557
22 ORTHOPNOEA 168 0.0527
23 HYPERVOLAEMIA 260 0.0526
24 INFUSION SITE HAEMORRHAGE 170 0.0516
25 DEVICE INFUSION ISSUE 128 0.0516
26 OBSTRUCTIVE SLEEP APNOEA SYNDROME 74 0.0507
27 AORTIC STENOSIS 176 0.0505
28 INFUSION SITE INDURATION 73 0.0492
29 OXYGEN CONSUMPTION INCREASED 111 0.0464
30 COLITIS MICROSCOPIC 212 0.0447
31 THERAPEUTIC AGENT TOXICITY 149 0.0446
32 HYPOKALAEMIA 2044 0.0442
33 RIGHT VENTRICULAR FAILURE 306 0.0436
34 BLOOD CHLORIDE DECREASED 112 0.0434
35 VASCULAR DEVICE INFECTION 194 0.0427
36 ISCHAEMIC CARDIOMYOPATHY 130 0.0424
37 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 213 0.0420
38 INFUSION SITE PAIN 537 0.0416
39 LYMPHOEDEMA 284 0.0410
40 BRAIN NATRIURETIC PEPTIDE INCREASED 124 0.0402
41 CATHETER SITE ERYTHEMA 86 0.0401
42 HAEMORRHAGIC ANAEMIA 175 0.0398
43 INFUSION SITE ERYTHEMA 334 0.0396
44 BREATH SOUNDS ABNORMAL 194 0.0393
45 CATHETER SITE HAEMORRHAGE 97 0.0387
46 HYPOPHOSPHATAEMIA 280 0.0378
47 ATELECTASIS 366 0.0378
48 BLOOD POTASSIUM DECREASED 1138 0.0378
49 INFUSION SITE SWELLING 238 0.0378
50 RALES 213 0.0366
51 HAEMOGLOBIN INCREASED 166 0.0364
52 VENTRICULAR FIBRILLATION 402 0.0362
53 INFUSION SITE REACTION 107 0.0358
54 PULMONARY HYPERTENSION 739 0.0354
55 MACULAR DEGENERATION 423 0.0354
56 REBOUND ACID HYPERSECRETION 104 0.0343
57 IRON DEFICIENCY 153 0.0340
58 HYPOVOLAEMIA 198 0.0338
59 MITRAL VALVE INCOMPETENCE 379 0.0335
60 CARDIOMEGALY 411 0.0334
61 CARDIOGENIC SHOCK 475 0.0331
62 SUPRAVENTRICULAR EXTRASYSTOLES 111 0.0328
63 BLOOD LOSS ANAEMIA 74 0.0326
64 METABOLIC ENCEPHALOPATHY 98 0.0326
65 TRICUSPID VALVE INCOMPETENCE 258 0.0324
66 HYPERLIPIDAEMIA 388 0.0324
67 HYPERKALAEMIA 1132 0.0322
68 ATRIOVENTRICULAR BLOCK FIRST DEGREE 139 0.0320
69 ATRIAL FLUTTER 255 0.0319
70 LEFT VENTRICULAR FAILURE 110 0.0319
71 OESOPHAGEAL PAIN 125 0.0316
72 PLEURITIC PAIN 87 0.0315
73 ACUTE RESPIRATORY FAILURE 605 0.0314
74 BLOOD URIC ACID INCREASED 178 0.0308
75 FAILURE TO THRIVE 160 0.0308
76 SEASONAL ALLERGY 432 0.0305
77 MULTIPLE INJURIES 192 0.0305
78 BLOOD POTASSIUM ABNORMAL 81 0.0304
79 LUNG CONSOLIDATION 82 0.0293
80 LEFT VENTRICULAR HYPERTROPHY 124 0.0289
81 PROTHROMBIN TIME PROLONGED 173 0.0289
82 APPENDICITIS 270 0.0289
83 HYPERCAPNIA 87 0.0289
84 BLOOD MAGNESIUM DECREASED 249 0.0288
85 INFUSION SITE PRURITUS 91 0.0288
86 HYPOMAGNESAEMIA 401 0.0288
87 FLUID OVERLOAD 419 0.0288
88 DIASTOLIC DYSFUNCTION 88 0.0285
89 LUNG OPACITY 74 0.0281
90 ELECTROLYTE IMBALANCE 325 0.0279
91 PULMONARY ARTERIAL HYPERTENSION 392 0.0270
92 CLOSTRIDIUM DIFFICILE COLITIS 286 0.0269
93 AORTIC VALVE INCOMPETENCE 114 0.0268
94 BUNDLE BRANCH BLOCK LEFT 113 0.0266
95 END STAGE RENAL DISEASE 484 0.0265
96 MYASTHENIA GRAVIS 214 0.0265
97 CARDIAC FAILURE CONGESTIVE 2128 0.0265
98 HYPERNATRAEMIA 132 0.0265
99 ECONOMIC PROBLEM 397 0.0262
100 ORAL CANDIDIASIS 343 0.0260
101 BLOOD UREA INCREASED 435 0.0260
102 LOWER GASTROINTESTINAL HAEMORRHAGE 191 0.0258
103 BLOOD ALBUMIN DECREASED 203 0.0256
104 INTERNATIONAL NORMALISED RATIO DECREASED 103 0.0254
105 BENIGN PROSTATIC HYPERPLASIA 131 0.0253
106 CHEST X-RAY ABNORMAL 77 0.0251
107 FLUID RETENTION 1277 0.0251
108 RENAL FAILURE CHRONIC 193 0.0251
109 CARDIAC MURMUR 215 0.0248
110 TROPONIN INCREASED 189 0.0248
111 DYSPNOEA EXERTIONAL 934 0.0248
112 LUNG INFILTRATION 219 0.0248
113 ARTERIOSCLEROSIS CORONARY ARTERY 164 0.0247
114 MULTIPLE ALLERGIES 190 0.0242
115 CYTOKINE RELEASE SYNDROME 486 0.0242
116 CARDIAC FAILURE CHRONIC 103 0.0241
117 ASCITES 706 0.0240
118 CONGESTIVE CARDIOMYOPATHY 100 0.0240
119 HYPOXIA 839 0.0238
120 HEPARIN-INDUCED THROMBOCYTOPENIA 117 0.0237
121 PERIPHERAL VASCULAR DISORDER 122 0.0237
122 TOXIC EPIDERMAL NECROLYSIS 357 0.0235
123 ELECTROCARDIOGRAM ABNORMAL 184 0.0234
124 CATHETER SITE INFECTION 88 0.0232
125 GOUT 416 0.0232
126 DERMATITIS CONTACT 264 0.0231
127 INTERNATIONAL NORMALISED RATIO INCREASED 660 0.0231
128 PROTEIN TOTAL DECREASED 87 0.0231
129 VENTRICULAR EXTRASYSTOLES 239 0.0230
130 CARDIAC FAILURE ACUTE 153 0.0229
131 VENTRICULAR TACHYCARDIA 379 0.0229
132 DIVERTICULUM 163 0.0229
133 PULSE ABSENT 109 0.0229
134 PNEUMONIA ASPIRATION 567 0.0227
135 RED CELL DISTRIBUTION WIDTH INCREASED 94 0.0226
136 ATRIAL FIBRILLATION 2190 0.0225
137 CAROTID ARTERY STENOSIS 78 0.0223
138 PEPTIC ULCER 74 0.0223
139 LEFT VENTRICULAR DYSFUNCTION 149 0.0222
140 HYPOALBUMINAEMIA 171 0.0220
141 EXERCISE TOLERANCE DECREASED 126 0.0219
142 RENAL FAILURE ACUTE 929 0.0219
143 IRON DEFICIENCY ANAEMIA 202 0.0219
144 MALNUTRITION 240 0.0214
145 AZOTAEMIA 85 0.0213
146 BLOOD CREATINE INCREASED 93 0.0210
147 CATHETERISATION CARDIAC 93 0.0210
148 CARDIAC VALVE DISEASE 119 0.0208
149 PLEURAL EFFUSION 1261 0.0207
150 GENERALISED OEDEMA 256 0.0207
151 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1074 0.0206
152 UPPER GASTROINTESTINAL HAEMORRHAGE 346 0.0205
153 HYPERURICAEMIA 84 0.0204
154 CARDIOMYOPATHY 301 0.0203
155 HAEMATOCRIT DECREASED 402 0.0203
156 OEDEMA PERIPHERAL 2463 0.0202
157 BLOOD POTASSIUM INCREASED 325 0.0200
158 SLEEP APNOEA SYNDROME 380 0.0199
159 MENTAL STATUS CHANGES 549 0.0197
160 HYPONATRAEMIA 1110 0.0197
161 CANDIDIASIS 78 0.0194
162 RENAL TUBULAR NECROSIS 190 0.0194
163 PARAESTHESIA ORAL 279 0.0193
164 HAEMORRHOIDAL HAEMORRHAGE 94 0.0192
165 EMPHYSEMA 193 0.0191
166 CHRONIC KIDNEY DISEASE 1448 0.0190
167 VAGINAL DISCHARGE 191 0.0189
168 BACTERAEMIA 224 0.0189
169 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 72 0.0188
170 PERICARDIAL EFFUSION 435 0.0188
171 COAGULOPATHY 313 0.0188
172 BUNDLE BRANCH BLOCK RIGHT 86 0.0187
173 PRODUCT RESIDUE PRESENT 101 0.0187
174 ARTERIOSCLEROSIS 176 0.0187
175 HOSPICE CARE 184 0.0186
176 FEBRILE NEUTROPENIA 1230 0.0185
177 TRANSFUSION 194 0.0185
178 STAPHYLOCOCCAL BACTERAEMIA 80 0.0184
179 HIATUS HERNIA 238 0.0184
180 GASTROINTESTINAL HAEMORRHAGE 1530 0.0183
181 DECUBITUS ULCER 149 0.0183
182 BACTERIAL INFECTION 341 0.0183
183 DIABETIC NEUROPATHY 90 0.0182
184 ACUTE KIDNEY INJURY 2775 0.0181
185 SMALL INTESTINAL OBSTRUCTION 223 0.0181
186 DYSLIPIDAEMIA 92 0.0181
187 SEPSIS 2015 0.0180
188 SUPRAVENTRICULAR TACHYCARDIA 172 0.0179
189 DIVERTICULITIS 497 0.0179
190 OXYGEN SATURATION DECREASED 1001 0.0178
191 LEUKOCYTOSIS 322 0.0178
192 PURULENT DISCHARGE 76 0.0178
193 ORTHOSTATIC HYPOTENSION 308 0.0177
194 DIVERTICULUM INTESTINAL 77 0.0176
195 OEDEMA 952 0.0175
196 RESPIRATORY FAILURE 1280 0.0175
197 SPINAL OSTEOARTHRITIS 153 0.0174
198 ESCHERICHIA URINARY TRACT INFECTION 74 0.0174
199 TACHYPNOEA 235 0.0173
200 UROSEPSIS 159 0.0172
201 PAIN IN JAW 488 0.0172
202 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 102 0.0172
203 PULMONARY OEDEMA 771 0.0172
204 GASTRITIS EROSIVE 80 0.0171
205 OESOPHAGITIS 187 0.0171
206 EJECTION FRACTION DECREASED 266 0.0171
207 HEPATIC CYTOLYSIS 218 0.0171
208 CELLULITIS 860 0.0170
209 STAPHYLOCOCCAL SEPSIS 84 0.0170
210 RENAL CYST 135 0.0170
211 RECTAL HAEMORRHAGE 728 0.0169
212 MULTIPLE ORGAN DYSFUNCTION SYNDROME 479 0.0169
213 HYDRONEPHROSIS 126 0.0168
214 BRONCHITIS 1240 0.0167
215 ACUTE PULMONARY OEDEMA 94 0.0167
216 MULTIPLE MYELOMA 78 0.0167
217 SHOCK HAEMORRHAGIC 136 0.0167
218 HYPOCALCAEMIA 315 0.0166
219 ANAEMIA 3172 0.0166
220 ENTEROCOCCAL INFECTION 80 0.0165
221 SEPTIC SHOCK 719 0.0165
222 AMMONIA INCREASED 84 0.0164
223 DEHYDRATION 2194 0.0164
224 BLOOD BILIRUBIN INCREASED 444 0.0164
225 COMPRESSION FRACTURE 88 0.0164
226 CORONARY ARTERY DISEASE 495 0.0163
227 BLOOD ALKALINE PHOSPHATASE INCREASED 405 0.0163
228 HYPOVOLAEMIC SHOCK 78 0.0163
229 CARDIAC PACEMAKER INSERTION 97 0.0163
230 CYSTITIS 514 0.0161
231 RENAL FAILURE 2123 0.0160
232 GLAUCOMA 307 0.0159
233 CARDIAC FAILURE 1278 0.0159
234 BLOOD CALCIUM INCREASED 139 0.0158
235 BLOOD SODIUM DECREASED 298 0.0158
236 ECCHYMOSIS 108 0.0157
237 HYPOTENSION 3158 0.0157
238 MULTI-ORGAN FAILURE 271 0.0157
239 URINE OUTPUT DECREASED 137 0.0157
240 SKIN ABRASION 74 0.0156
241 TORSADE DE POINTES 122 0.0155
242 ABDOMINAL TENDERNESS 77 0.0155
243 PROTEIN URINE PRESENT 77 0.0154
244 HYPERCHOLESTEROLAEMIA 149 0.0154
245 SINUS BRADYCARDIA 149 0.0154
246 SKIN LACERATION 167 0.0153
247 HUMERUS FRACTURE 74 0.0153
248 COLITIS 581 0.0153
249 RESPIRATORY DISTRESS 420 0.0152
250 ILEUS 188 0.0151
251 PULMONARY CONGESTION 199 0.0151
252 CHOLECYSTITIS ACUTE 85 0.0150
253 LYMPHOCYTE COUNT DECREASED 265 0.0150
254 PRODUCTIVE COUGH 715 0.0150
255 PANCYTOPENIA 836 0.0149
256 CORONARY ARTERY STENOSIS 75 0.0149
257 ULCER 236 0.0148
258 INTERVERTEBRAL DISC DEGENERATION 137 0.0148
259 FAECAL INCONTINENCE 71 0.0148
260 COVID-19 PNEUMONIA 174 0.0147
261 SINUS TACHYCARDIA 209 0.0147
262 INTESTINAL ISCHAEMIA 81 0.0147
263 GASTROOESOPHAGEAL REFLUX DISEASE 1184 0.0147
264 NEUTROPENIC SEPSIS 105 0.0147
265 BLOOD CREATININE INCREASED 956 0.0146
266 HAEMOPTYSIS 407 0.0146
267 TUMOUR LYSIS SYNDROME 128 0.0145
268 DEVICE RELATED INFECTION 222 0.0144
269 BLOOD CALCIUM DECREASED 162 0.0144
270 BODY HEIGHT DECREASED 154 0.0144
271 PULMONARY MASS 214 0.0144
272 HAEMORRHOIDS 280 0.0143
273 ADRENAL INSUFFICIENCY 174 0.0143
274 DIZZINESS POSTURAL 139 0.0143
275 ENCEPHALOPATHY 352 0.0143
276 SPUTUM DISCOLOURED 135 0.0142
277 SCOLIOSIS 88 0.0142
278 ESCHERICHIA INFECTION 116 0.0141
279 EXTRASYSTOLES 98 0.0140
280 RENAL INJURY 417 0.0140
281 PNEUMONIA 4544 0.0140
282 OBESITY 223 0.0140
283 MELAENA 308 0.0140
284 ASPIRATION 153 0.0140
285 EPISTAXIS 1043 0.0139
286 HYPERCALCAEMIA 172 0.0139
287 FULL BLOOD COUNT DECREASED 280 0.0139
288 HEPATIC ENCEPHALOPATHY 129 0.0138
289 CACHEXIA 71 0.0138
290 HEART RATE IRREGULAR 311 0.0137
291 VITAMIN D DEFICIENCY 134 0.0137
292 SUBDURAL HAEMATOMA 196 0.0137
293 PNEUMONIA BACTERIAL 125 0.0136
294 ATRIOVENTRICULAR BLOCK COMPLETE 91 0.0136
295 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 232 0.0135
296 HAEMOGLOBIN DECREASED 1388 0.0135
297 HAEMODIALYSIS 113 0.0134
298 C-REACTIVE PROTEIN INCREASED 488 0.0134
299 UPPER RESPIRATORY TRACT INFECTION 618 0.0134
300 HAEMATOMA 346 0.0133
301 BRADYCARDIA 708 0.0133
302 POLYURIA 109 0.0133
303 PSEUDOMONAS INFECTION 113 0.0132
304 HYPERBILIRUBINAEMIA 136 0.0131
305 INTERNAL HAEMORRHAGE 150 0.0131
306 ANHEDONIA 344 0.0131
307 BLOOD IRON DECREASED 155 0.0130
308 FULL BLOOD COUNT ABNORMAL 138 0.0130
309 RED BLOOD CELL COUNT DECREASED 372 0.0130
310 CARDIAC ARREST 1071 0.0130
311 NEURALGIA 314 0.0129
312 WEIGHT FLUCTUATION 134 0.0128
313 ATRIOVENTRICULAR BLOCK 99 0.0128
314 NEUTROPHIL COUNT INCREASED 131 0.0128
315 TRANSIENT ISCHAEMIC ATTACK 431 0.0128
316 UPPER-AIRWAY COUGH SYNDROME 105 0.0127
317 HEART RATE ABNORMAL 71 0.0127
318 REFUSAL OF TREATMENT BY PATIENT 83 0.0127
319 GASTROENTERITIS 185 0.0127
320 CHOLECYSTITIS 151 0.0127
321 CHOLELITHIASIS 414 0.0126
322 CARDIAC FLUTTER 81 0.0125
323 BLOOD TEST ABNORMAL 176 0.0125
324 UNRESPONSIVE TO STIMULI 323 0.0125
325 PLATELET COUNT DECREASED 1331 0.0125
326 CATARACT OPERATION 74 0.0125
327 ASPARTATE AMINOTRANSFERASE INCREASED 662 0.0124
328 SYNOVITIS 224 0.0124
329 HAEMORRHAGIC STROKE 97 0.0124
330 PRESYNCOPE 301 0.0124
331 GLOMERULAR FILTRATION RATE DECREASED 152 0.0124
332 COMA 588 0.0123
333 URINARY TRACT INFECTION 2103 0.0123
334 ANGINA UNSTABLE 80 0.0123
335 MYOCARDIAL ISCHAEMIA 140 0.0123
336 ACUTE MYOCARDIAL INFARCTION 362 0.0123
337 HYPERGLYCAEMIA 446 0.0122
338 SPINAL COMPRESSION FRACTURE 101 0.0122
339 RESPIRATORY TRACT CONGESTION 194 0.0122
340 INCREASED TENDENCY TO BRUISE 112 0.0122
341 PROCEDURAL PAIN 337 0.0121
342 PYELONEPHRITIS 105 0.0121
343 FREQUENT BOWEL MOVEMENTS 327 0.0121
344 CLOSTRIDIUM DIFFICILE INFECTION 264 0.0121
345 DYSPNOEA 6840 0.0121
346 STAPHYLOCOCCAL INFECTION 398 0.0121
347 CONSTIPATION 2625 0.0120
348 FIBROMYALGIA 292 0.0120
349 HEAD INJURY 380 0.0120
350 BLOOD PRESSURE DECREASED 793 0.0119
351 BRONCHIECTASIS 80 0.0119
352 COLITIS ISCHAEMIC 80 0.0118
353 ABDOMINAL DISTENSION 1236 0.0118
354 THROMBOCYTOPENIA 1322 0.0118
355 PRODUCT ADMINISTRATION INTERRUPTED 92 0.0117
356 LUNG INFECTION 182 0.0117
357 RESPIRATORY SYNCYTIAL VIRUS INFECTION 102 0.0117
358 ELECTROCARDIOGRAM QT PROLONGED 419 0.0116
359 SINUS DISORDER 230 0.0116
360 THYROID DISORDER 179 0.0116
361 DEEP VEIN THROMBOSIS 754 0.0116
362 NERVE COMPRESSION 107 0.0116
363 DEMENTIA 323 0.0115
364 TENDERNESS 120 0.0115
365 PETECHIAE 120 0.0115
366 SYNCOPE 1147 0.0115
367 CANDIDA INFECTION 193 0.0114
368 NEPHROPATHY 106 0.0113
369 MYOPATHY 98 0.0113
370 HEPATIC CIRRHOSIS 213 0.0113
371 SINUS CONGESTION 153 0.0113
372 RESPIRATORY RATE INCREASED 100 0.0113
373 LOCALISED INFECTION 272 0.0112
374 PSYCHOLOGICAL TRAUMA 97 0.0112
375 SCIATICA 179 0.0112
376 WALKING AID USER 74 0.0112
377 PULMONARY THROMBOSIS 122 0.0112
378 ASTHENIA 4206 0.0112
379 MOUTH HAEMORRHAGE 82 0.0112
380 DIABETES MELLITUS INADEQUATE CONTROL 198 0.0112
381 SPLENOMEGALY 131 0.0112
382 PARKINSONISM 109 0.0112
383 ARRHYTHMIA 529 0.0112
384 LARGE INTESTINE POLYP 77 0.0111
385 WHITE BLOOD CELL COUNT INCREASED 426 0.0111
386 TASTE DISORDER 225 0.0111
387 DEVICE OCCLUSION 156 0.0111
388 FALL 3687 0.0111
389 IMPAIRED GASTRIC EMPTYING 151 0.0111
390 NEUTROPHIL COUNT DECREASED 450 0.0110
391 PERIPHERAL SWELLING 1697 0.0110
392 POLYP 72 0.0110
393 PULMONARY HAEMORRHAGE 86 0.0110
394 WOUND INFECTION 120 0.0109
395 HAEMATURIA 375 0.0109
396 GASTRITIS 288 0.0109
397 CIRCULATORY COLLAPSE 186 0.0109
398 ACUTE RESPIRATORY DISTRESS SYNDROME 193 0.0109
399 HEPATOMEGALY 107 0.0109
400 TUBULOINTERSTITIAL NEPHRITIS 204 0.0109
401 HYPOPHAGIA 278 0.0109
402 HYPOGLYCAEMIA 525 0.0108
403 CHEST PAIN 2001 0.0108
404 LABORATORY TEST ABNORMAL 318 0.0108
405 MICTURITION URGENCY 123 0.0108
406 WRIST FRACTURE 129 0.0108
407 LACERATION 101 0.0107
408 GASTRIC ULCER 204 0.0107
409 HAEMATOCHEZIA 592 0.0107
410 WEIGHT DECREASED 2992 0.0107
411 PULMONARY EMBOLISM 1016 0.0107
412 HEPATIC STEATOSIS 199 0.0107
413 FLANK PAIN 100 0.0107
414 DIARRHOEA 6883 0.0107
415 PELVIC FRACTURE 83 0.0106
416 ALANINE AMINOTRANSFERASE INCREASED 654 0.0106
417 ABDOMINAL PAIN 2476 0.0106
418 SUBARACHNOID HAEMORRHAGE 108 0.0106
419 NEUROPATHY PERIPHERAL 1008 0.0106
420 CORONARY ARTERY OCCLUSION 145 0.0106
421 BLOOD PRESSURE DIASTOLIC DECREASED 78 0.0106
422 RIB FRACTURE 217 0.0105
423 NOCTURIA 128 0.0105
424 JOINT INJURY 225 0.0105
425 HYPOTHYROIDISM 336 0.0105
426 AORTIC ANEURYSM 80 0.0105
427 OSTEOARTHRITIS 444 0.0105
428 DISSEMINATED INTRAVASCULAR COAGULATION 147 0.0104
429 CARDIO-RESPIRATORY ARREST 436 0.0104
430 TACHYCARDIA 924 0.0104
431 WHITE BLOOD CELL COUNT DECREASED 1125 0.0104
432 BLOOD PRESSURE ABNORMAL 206 0.0104
433 PNEUMONITIS 282 0.0103
434 MUSCULOSKELETAL CHEST PAIN 160 0.0103
435 COUGH 2897 0.0103
436 INCONTINENCE 109 0.0103
437 DECREASED APPETITE 2392 0.0103
438 JOINT EFFUSION 71 0.0103
439 THROMBOSIS 822 0.0102
440 CONTUSION 981 0.0102
441 DYSURIA 375 0.0102
442 CYANOSIS 160 0.0102
443 POST PROCEDURAL COMPLICATION 195 0.0101
444 PLASMA CELL MYELOMA 395 0.0101
445 HAEMODYNAMIC INSTABILITY 77 0.0101
446 ACIDOSIS 77 0.0101
447 OSTEOPOROSIS 414 0.0101
448 RESPIRATORY TRACT INFECTION 262 0.0100
449 PNEUMOTHORAX 159 0.0100
450 GENERAL PHYSICAL HEALTH DETERIORATION 1160 0.0100
451 ANOREXIA 129 0.0100
452 ACUTE MYELOID LEUKAEMIA 156 0.0100
453 SKIN REACTION 141 0.0100
454 MOTOR DYSFUNCTION 102 0.0100
455 GASTROENTERITIS VIRAL 180 0.0100
456 NASAL CONGESTION 585 0.0099
457 HYPERTHYROIDISM 144 0.0099
458 SKIN ULCER 257 0.0099
459 LIGAMENT SPRAIN 98 0.0099
460 INTERVERTEBRAL DISC PROTRUSION 216 0.0099
461 EMBOLISM 82 0.0099
462 KIDNEY INFECTION 193 0.0098
463 PURPURA 87 0.0098
464 HAEMOLYTIC ANAEMIA 88 0.0098
465 OSTEOPENIA 149 0.0098
466 LUNG DISORDER 481 0.0098
467 BLOOD PRESSURE SYSTOLIC INCREASED 191 0.0098
468 BOWEL MOVEMENT IRREGULARITY 75 0.0098
469 GROIN PAIN 86 0.0098
470 AGRANULOCYTOSIS 181 0.0097
471 HERNIA 188 0.0097
472 POST PROCEDURAL HAEMORRHAGE 113 0.0097
473 HAEMORRHAGE INTRACRANIAL 145 0.0097
474 ANAL INCONTINENCE 87 0.0097
475 GAMMA-GLUTAMYLTRANSFERASE INCREASED 214 0.0096
476 URINARY RETENTION 322 0.0096
477 RETCHING 205 0.0096
478 HYPERTHERMIA 73 0.0096
479 OSTEOMYELITIS 173 0.0095
480 URINARY INCONTINENCE 283 0.0095
481 RESTLESS LEGS SYNDROME 173 0.0095
482 STOMATITIS 575 0.0095
483 FAECES DISCOLOURED 205 0.0094
484 BLOOD THYROID STIMULATING HORMONE INCREASED 87 0.0094
485 WHEEZING 560 0.0094
486 DYSPEPSIA 927 0.0094
487 HEPATIC FAILURE 284 0.0094
488 METABOLIC ACIDOSIS 301 0.0094
489 CHEST DISCOMFORT 960 0.0094
490 CHOLESTASIS 180 0.0094
491 SINUSITIS 959 0.0093
492 INITIAL INSOMNIA 96 0.0093
493 LIMB INJURY 254 0.0093
494 HEART RATE DECREASED 328 0.0093
495 TOOTH ABSCESS 95 0.0093
496 BACK PAIN 2167 0.0093
497 PANCREATITIS ACUTE 209 0.0093
498 GINGIVAL PAIN 74 0.0093
499 DECREASED ACTIVITY 100 0.0093
500 SHOCK 213 0.0093
501 DRUG INTERACTION 1467 0.0092
502 BLOOD DISORDER 74 0.0092
503 HIP FRACTURE 297 0.0092
504 OROPHARYNGEAL DISCOMFORT 83 0.0092
505 LOW BIRTH WEIGHT BABY 73 0.0092
506 ATAXIA 109 0.0092
507 CONFUSIONAL STATE 1477 0.0091
508 HEREDITARY ANGIOEDEMA 98 0.0091
509 MUCOSAL INFLAMMATION 239 0.0091
510 RASH MACULO-PAPULAR 203 0.0091
511 ORAL PAIN 204 0.0091
512 PYREXIA 3152 0.0091
513 LACTIC ACIDOSIS 295 0.0091
514 RENAL IMPAIRMENT 765 0.0091
515 HYPERTENSION 1921 0.0091
516 ACUTE CORONARY SYNDROME 75 0.0090
517 STENT PLACEMENT 73 0.0090
518 ANKLE FRACTURE 140 0.0090
519 HALLUCINATION 681 0.0090
520 GASTROINTESTINAL INFECTION 81 0.0090
521 BLOOD LACTATE DEHYDROGENASE INCREASED 143 0.0090
522 INJURY 634 0.0090
523 PERITONITIS BACTERIAL 91 0.0090
524 DIABETES MELLITUS 687 0.0090
525 THERAPY NON-RESPONDER 405 0.0090
526 VOMITING 4216 0.0090
527 GALLBLADDER DISORDER 160 0.0090
528 FACIAL PAIN 80 0.0090
529 BURSITIS 108 0.0089
530 DRY MOUTH 722 0.0089
531 HEART RATE INCREASED 881 0.0089
532 SECRETION DISCHARGE 111 0.0089
533 BLOOD CHOLESTEROL INCREASED 413 0.0089
534 HAIR DISORDER 73 0.0089
535 BLOOD URINE PRESENT 168 0.0088
536 SKIN INFECTION 99 0.0088
537 NEUTROPENIA 1197 0.0088
538 NECK PAIN 491 0.0088
539 SWELLING 822 0.0088
540 FEEDING DISORDER 178 0.0088
541 ABSCESS 140 0.0088
542 BLADDER DISORDER 87 0.0088
543 BONE MARROW FAILURE 178 0.0088
544 CARDIAC DISORDER 818 0.0087
545 TOXIC SKIN ERUPTION 88 0.0087
546 HYPERSOMNIA 250 0.0087
547 THROAT IRRITATION 391 0.0087
548 LETHARGY 501 0.0087
549 INFUSION RELATED REACTION 576 0.0087
550 MUSCULOSKELETAL PAIN 455 0.0087
551 BLOOD COUNT ABNORMAL 131 0.0086
552 PRODUCT DISTRIBUTION ISSUE 80 0.0086
553 FEAR 231 0.0086
554 LIVER FUNCTION TEST ABNORMAL 249 0.0086
555 MUSCULAR WEAKNESS 972 0.0085
556 INSURANCE ISSUE 130 0.0085
557 HEMIPARESIS 144 0.0085
558 DENTAL CARIES 94 0.0085
559 LIVER FUNCTION TEST INCREASED 182 0.0085
560 BEDRIDDEN 111 0.0084
561 HAEMATEMESIS 214 0.0084
562 MUSCULOSKELETAL DISCOMFORT 145 0.0084
563 GINGIVAL BLEEDING 115 0.0084
564 UNEVALUABLE EVENT 637 0.0084
565 PALPITATIONS 986 0.0084
566 STEVENS-JOHNSON SYNDROME 187 0.0084
567 TRANSAMINASES INCREASED 187 0.0084
568 ROTATOR CUFF SYNDROME 108 0.0084
569 MOUTH ULCERATION 177 0.0084
570 IMMUNODEFICIENCY 125 0.0084
571 DELIRIUM 291 0.0084
572 NAUSEA 6627 0.0084
573 VIRAL INFECTION 278 0.0083
574 EXOSTOSIS 76 0.0083
575 SOMNOLENCE 1674 0.0083
576 EAR DISCOMFORT 85 0.0083
577 IMPAIRED QUALITY OF LIFE 119 0.0083
578 ANURIA 71 0.0082
579 CYTOPENIA 101 0.0082
580 BACK DISORDER 134 0.0082
581 RENAL DISORDER 384 0.0082
582 FATIGUE 6413 0.0082
583 MASS 115 0.0082
584 DYSPHONIA 481 0.0082
585 FUNGAL INFECTION 274 0.0082
586 DISEASE PROGRESSION 971 0.0082
587 FOOT FRACTURE 155 0.0082
588 DYSPHAGIA 776 0.0082
589 INTESTINAL OBSTRUCTION 308 0.0082
590 CHILLS 957 0.0082
591 DYSARTHRIA 307 0.0081
592 FLUSHING 828 0.0081
593 RED BLOOD CELL SEDIMENTATION RATE INCREASED 90 0.0081
594 PULMONARY FIBROSIS 156 0.0081
595 PRODUCT USE COMPLAINT 128 0.0081
596 DIZZINESS 4051 0.0081
597 BALANCE DISORDER 702 0.0081
598 CATARACT 482 0.0081
599 TYPE 2 DIABETES MELLITUS 272 0.0081
600 DRUG TOXICITY 110 0.0081
601 BRAIN OEDEMA 102 0.0081
602 SQUAMOUS CELL CARCINOMA 76 0.0081
603 NEPHROLITHIASIS 370 0.0081
604 HAIR COLOUR CHANGES 100 0.0080
605 RESPIRATORY ARREST 221 0.0080
606 NERVE INJURY 89 0.0080
607 ANGINA PECTORIS 229 0.0080
608 BODY TEMPERATURE INCREASED 163 0.0080
609 EAR PAIN 155 0.0080
610 EYE INFECTION 90 0.0080
611 DIALYSIS 113 0.0080
612 BLOOD TRIGLYCERIDES INCREASED 140 0.0079
613 APHASIA 239 0.0079
614 CEREBRAL HAEMORRHAGE 282 0.0079
615 POLLAKIURIA 327 0.0078
616 PAIN IN EXTREMITY 2308 0.0078
617 FLATULENCE 444 0.0078
618 BONE DISORDER 142 0.0078
619 SPINAL FRACTURE 156 0.0078
620 ISCHAEMIC STROKE 138 0.0077
621 HYPOTONIA 77 0.0077
622 COMPLICATION ASSOCIATED WITH DEVICE 112 0.0077
623 NO THERAPEUTIC RESPONSE 94 0.0077
624 RHABDOMYOLYSIS 321 0.0077
625 JAUNDICE 207 0.0077
626 RESPIRATORY DISORDER 230 0.0077
627 BLOOD PRESSURE INCREASED 1175 0.0077
628 INFLUENZA 856 0.0077
629 FEELING COLD 213 0.0076
630 CARPAL TUNNEL SYNDROME 107 0.0076
631 MYELODYSPLASTIC SYNDROME 110 0.0076
632 WEIGHT INCREASED 1702 0.0076
633 EAR INFECTION 202 0.0076
634 UPPER LIMB FRACTURE 151 0.0076
635 HYPOKINESIA 110 0.0076
636 ILLNESS 780 0.0076
637 ABASIA 187 0.0076
638 JOINT DISLOCATION 80 0.0076
639 HERPES ZOSTER 434 0.0075
640 DRUG INTOLERANCE 728 0.0075
641 TINNITUS 346 0.0075
642 TOOTH INFECTION 99 0.0075
643 AGEUSIA 187 0.0075
644 BLOOD PRESSURE FLUCTUATION 179 0.0074
645 ARTHRITIS 586 0.0074
646 COLD SWEAT 131 0.0074
647 HAIR TEXTURE ABNORMAL 99 0.0074
648 DISORIENTATION 293 0.0074
649 MUSCLE SPASMS 1354 0.0074
650 TOOTH FRACTURE 81 0.0073
651 LEUKOPENIA 366 0.0073
652 SLEEP DISORDER 516 0.0073
653 BLISTER 409 0.0073
654 SUDDEN DEATH 77 0.0073
655 BRAIN FOG 114 0.0073
656 INTERSTITIAL LUNG DISEASE 352 0.0073
657 PROSTATIC SPECIFIC ANTIGEN INCREASED 100 0.0073
658 MYOCARDIAL INFARCTION 1266 0.0073
659 RHINORRHOEA 469 0.0072
660 INFECTION 1050 0.0072
661 ABDOMINAL PAIN UPPER 1482 0.0072
662 LOSS OF CONSCIOUSNESS 922 0.0072
663 HYPERHIDROSIS 927 0.0072
664 EOSINOPHILIA 126 0.0072
665 TEMPERATURE INTOLERANCE 74 0.0072
666 DRUG LEVEL INCREASED 118 0.0071
667 DYSSTASIA 208 0.0071
668 HYPOTHERMIA 72 0.0071
669 EATING DISORDER 151 0.0071
670 GASTROINTESTINAL DISORDER 635 0.0071
671 PRODUCT ADMINISTRATION ERROR 143 0.0071
672 TREATMENT NONCOMPLIANCE 387 0.0071
673 PALLOR 192 0.0070
674 PERITONITIS 146 0.0070
675 DEPRESSION 1602 0.0070
676 GASTRIC HAEMORRHAGE 81 0.0070
677 SKIN LESION 193 0.0070
678 SKIN DISCOLOURATION 323 0.0070
679 DEVICE FAILURE 107 0.0070
680 OROPHARYNGEAL PAIN 650 0.0070
681 TREMOR 1160 0.0070
682 INJECTION SITE EXTRAVASATION 86 0.0070
683 BONE PAIN 408 0.0070
684 GAIT DISTURBANCE 1332 0.0070
685 BRONCHOSPASM 99 0.0069
686 EYE DISCHARGE 72 0.0069
687 LYMPHOPENIA 98 0.0069
688 ACTIVITIES OF DAILY LIVING IMPAIRED 136 0.0069
689 HALLUCINATION, VISUAL 145 0.0069
690 AGITATION 504 0.0069
691 TOOTHACHE 124 0.0068
692 CONJUNCTIVITIS 127 0.0068
693 BLOOD GLUCOSE FLUCTUATION 75 0.0068
694 BLOOD GLUCOSE DECREASED 328 0.0068
695 HEADACHE 4281 0.0068
696 ANXIETY 1943 0.0068
697 STATUS EPILEPTICUS 77 0.0068
698 ABDOMINAL DISCOMFORT 1140 0.0068
699 LACRIMATION INCREASED 205 0.0068
700 METASTASES TO CENTRAL NERVOUS SYSTEM 87 0.0067
701 CONDITION AGGRAVATED 2046 0.0067
702 MALAISE 2943 0.0067
703 INTESTINAL PERFORATION 75 0.0067
704 TOOTH DISORDER 148 0.0066
705 AMNESIA 433 0.0066
706 OBSTRUCTIVE AIRWAYS DISORDER 74 0.0066
707 DEPRESSED LEVEL OF CONSCIOUSNESS 263 0.0066
708 MUSCLE ATROPHY 84 0.0066
709 CEREBROVASCULAR ACCIDENT 1123 0.0066
710 HAEMORRHAGE 692 0.0066
711 MOBILITY DECREASED 475 0.0066
712 SCAR 113 0.0066
713 METASTASES TO LIVER 116 0.0066
714 PLATELET COUNT INCREASED 86 0.0066
715 TOOTH EXTRACTION 82 0.0066
716 COLON CANCER 98 0.0066
717 LOWER LIMB FRACTURE 126 0.0066
718 ASTHMA 740 0.0065
719 PROTEINURIA 124 0.0065
720 LIVER DISORDER 289 0.0065
721 COVID-19 1143 0.0065
722 EYE PAIN 367 0.0065
723 FEMUR FRACTURE 201 0.0065
724 PANCREATITIS 342 0.0065
725 DIPLOPIA 168 0.0065
726 MIGRAINE 617 0.0065
727 JOINT SWELLING 780 0.0065
728 MYOCLONUS 77 0.0064
729 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 309 0.0064
730 CEREBRAL INFARCTION 157 0.0064
731 HEPATIC ENZYME INCREASED 438 0.0064
732 NIGHT SWEATS 207 0.0064
733 HYPOAESTHESIA 960 0.0064
734 OCULAR DISCOMFORT 72 0.0064
735 SKIN HAEMORRHAGE 95 0.0064
736 CHOLECYSTECTOMY 73 0.0064
737 PAIN 3918 0.0064
738 WOUND 178 0.0064
739 MUSCLE RIGIDITY 76 0.0063
740 LIMB DISCOMFORT 196 0.0063
741 LYMPHADENOPATHY 224 0.0063
742 FEELING ABNORMAL 1513 0.0063
743 SNEEZING 141 0.0063
744 THERAPY PARTIAL RESPONDER 98 0.0063
745 NEUROTOXICITY 110 0.0063
746 COLITIS ULCERATIVE 280 0.0063
747 PERIPHERAL COLDNESS 86 0.0063
748 SPINAL OPERATION 77 0.0062
749 CONTRAINDICATED PRODUCT ADMINISTERED 189 0.0062
750 BLOOD GLUCOSE INCREASED 1176 0.0062
751 COMPLETED SUICIDE 516 0.0062
752 NEOPLASM 71 0.0062
753 PHOTOPHOBIA 115 0.0061
754 MULTIPLE FRACTURES 100 0.0061
755 IMMUNE SYSTEM DISORDER 80 0.0061
756 RASH PRURITIC 328 0.0060
757 JOINT RANGE OF MOTION DECREASED 81 0.0060
758 NASOPHARYNGITIS 1112 0.0060
759 BASAL CELL CARCINOMA 94 0.0060
760 LOCAL SWELLING 105 0.0060
761 INSOMNIA 1600 0.0060
762 VISION BLURRED 823 0.0060
763 MEDICATION ERROR 333 0.0060
764 CHOKING 116 0.0059
765 POOR QUALITY SLEEP 128 0.0059
766 GASTRIC DISORDER 204 0.0059
767 BLOOD CREATINE PHOSPHOKINASE INCREASED 171 0.0059
768 THIRST 106 0.0059
769 GAIT INABILITY 198 0.0059
770 NODULE 77 0.0059
771 PHARMACEUTICAL PRODUCT COMPLAINT 153 0.0059
772 MEMORY IMPAIRMENT 808 0.0059
773 SPEECH DISORDER 307 0.0059
774 ARTHRALGIA 2432 0.0058
775 CONVULSION 334 0.0058
776 ERUCTATION 113 0.0058
777 RESTLESSNESS 213 0.0058
778 COGNITIVE DISORDER 271 0.0058
779 MYALGIA 982 0.0058
780 MALIGNANT NEOPLASM PROGRESSION 590 0.0058
781 SWELLING FACE 375 0.0058
782 PRESCRIBED UNDERDOSE 114 0.0057
783 CARDIOVASCULAR DISORDER 145 0.0057
784 HEAD DISCOMFORT 101 0.0057
785 ARTHROPATHY 317 0.0057
786 ERYTHEMA 1169 0.0057
787 HOT FLUSH 427 0.0057
788 IMPAIRED HEALING 186 0.0057
789 DELUSION 88 0.0057
790 KNEE ARTHROPLASTY 119 0.0056
791 PRODUCT DOSE OMISSION IN ERROR 160 0.0056
792 NERVOUSNESS 295 0.0056
793 HYPOACUSIS 243 0.0056
794 MUSCLE TIGHTNESS 91 0.0056
795 VERTIGO 341 0.0056
796 HEPATIC FUNCTION ABNORMAL 208 0.0056
797 PREMATURE BABY 167 0.0055
798 FEELING HOT 340 0.0055
799 INTENTIONAL DOSE OMISSION 158 0.0055
800 ALTERED STATE OF CONSCIOUSNESS 120 0.0055
801 APHONIA 77 0.0055
802 ROAD TRAFFIC ACCIDENT 230 0.0055
803 LOWER RESPIRATORY TRACT INFECTION 249 0.0055
804 RASH MACULAR 191 0.0055
805 RASH ERYTHEMATOUS 259 0.0054
806 DEATH 4665 0.0054
807 EYE DISORDER 178 0.0054
808 FEELING JITTERY 103 0.0054
809 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 384 0.0054
810 CYTOMEGALOVIRUS INFECTION 89 0.0053
811 HIP ARTHROPLASTY 82 0.0053
812 INCREASED APPETITE 102 0.0053
813 PRODUCT DOSE OMISSION ISSUE 1568 0.0053
814 IRRITABLE BOWEL SYNDROME 114 0.0053
815 PARALYSIS 76 0.0053
816 ACCIDENTAL OVERDOSE 194 0.0053
817 PARAESTHESIA 831 0.0053
818 PRURITUS GENERALISED 114 0.0053
819 EYE SWELLING 195 0.0052
820 METASTASES TO BONE 86 0.0052
821 COORDINATION ABNORMAL 73 0.0052
822 DYSGEUSIA 388 0.0052
823 THERAPY INTERRUPTED 373 0.0052
824 SWOLLEN TONGUE 163 0.0052
825 OSTEONECROSIS OF JAW 129 0.0052
826 PRODUCT DOSE OMISSION 340 0.0052
827 HOSPITALISATION 800 0.0052
828 DEAFNESS 136 0.0052
829 CHROMATURIA 117 0.0052
830 MIDDLE INSOMNIA 96 0.0051
831 MUSCLE TWITCHING 118 0.0051
832 NERVOUS SYSTEM DISORDER 158 0.0051
833 PRODUCT PRESCRIBING ERROR 120 0.0050
834 SKIN FISSURES 97 0.0050
835 RASH 2162 0.0050
836 PRURITUS 1901 0.0049
837 PERICARDITIS 83 0.0049
838 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 115 0.0049
839 MUSCULOSKELETAL STIFFNESS 431 0.0049
840 ALOPECIA 960 0.0049
841 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 83 0.0049
842 INTENTIONAL PRODUCT MISUSE 427 0.0049
843 GLYCOSYLATED HAEMOGLOBIN INCREASED 123 0.0049
844 BURNING SENSATION 340 0.0048
845 DRUG-INDUCED LIVER INJURY 152 0.0048
846 VISUAL IMPAIRMENT 595 0.0048
847 DIABETIC KETOACIDOSIS 115 0.0048
848 ABDOMINAL PAIN LOWER 121 0.0048
849 HYPOAESTHESIA ORAL 72 0.0048
850 SKIN DISORDER 159 0.0048
851 LIVER INJURY 116 0.0047
852 ILL-DEFINED DISORDER 287 0.0047
853 GENERALISED TONIC-CLONIC SEIZURE 78 0.0047
854 OFF LABEL USE 4119 0.0047
855 SURGERY 274 0.0047
856 THINKING ABNORMAL 87 0.0047
857 BLINDNESS 190 0.0047
858 OCULAR HYPERAEMIA 221 0.0047
859 BLOOD GLUCOSE ABNORMAL 86 0.0047
860 DRY EYE 231 0.0046
861 RASH PAPULAR 103 0.0046
862 HEPATITIS 117 0.0046
863 SEIZURE 525 0.0045
864 NEOPLASM PROGRESSION 158 0.0045
865 ANAPHYLACTIC REACTION 251 0.0045
866 LIP SWELLING 151 0.0045
867 THROAT TIGHTNESS 122 0.0045
868 SENSORY DISTURBANCE 72 0.0045
869 INFLAMMATION 231 0.0045
870 JOINT STIFFNESS 117 0.0045
871 PREMATURE DELIVERY 71 0.0045
872 DYSKINESIA 181 0.0044
873 DERMATITIS 93 0.0044
874 DEVICE DISLOCATION 192 0.0044
875 SKIN CANCER 95 0.0044
876 PRODUCT USE ISSUE 829 0.0044
877 RASH GENERALISED 114 0.0044
878 PANIC ATTACK 160 0.0044
879 EMOTIONAL DISTRESS 531 0.0044
880 VISUAL ACUITY REDUCED 145 0.0044
881 EYE IRRITATION 251 0.0044
882 INTENTIONAL PRODUCT USE ISSUE 378 0.0043
883 SKIN EXFOLIATION 362 0.0043
884 MENTAL DISORDER 186 0.0043
885 MENTAL IMPAIRMENT 103 0.0042
886 SEDATION 111 0.0042
887 EMOTIONAL DISORDER 130 0.0042
888 DISCOMFORT 256 0.0042
889 MYELOSUPPRESSION 151 0.0042
890 INFLUENZA LIKE ILLNESS 344 0.0042
891 EYE PRURITUS 137 0.0041
892 MUSCULOSKELETAL DISORDER 77 0.0040
893 DEVICE LEAKAGE 175 0.0040
894 PRODUCT USE IN UNAPPROVED INDICATION 999 0.0040
895 DISTURBANCE IN ATTENTION 216 0.0040
896 DRY SKIN 534 0.0040
897 RHEUMATOID ARTHRITIS 454 0.0040
898 ORAL HERPES 78 0.0040
899 HYPERSENSITIVITY 740 0.0040
900 GLOSSODYNIA 89 0.0040
901 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 712 0.0039
902 THERAPEUTIC RESPONSE UNEXPECTED 177 0.0039
903 MOVEMENT DISORDER 125 0.0039
904 TOXICITY TO VARIOUS AGENTS 655 0.0039
905 URTICARIA 637 0.0038
906 WRONG TECHNIQUE IN DRUG USAGE PROCESS 137 0.0038
907 DEPRESSED MOOD 199 0.0038
908 TOOTH LOSS 78 0.0038
909 NIGHTMARE 130 0.0038
910 FRACTURE 71 0.0037
911 SYSTEMIC LUPUS ERYTHEMATOSUS 133 0.0037
912 ADVERSE DRUG REACTION 336 0.0037
913 THERAPY CESSATION 192 0.0037
914 PSYCHOTIC DISORDER 110 0.0037
915 LUNG NEOPLASM MALIGNANT 152 0.0037
916 ABNORMAL DREAMS 102 0.0037
917 NEOPLASM MALIGNANT 245 0.0037
918 HEPATOTOXICITY 81 0.0036
919 OSTEONECROSIS 119 0.0036
920 ECZEMA 187 0.0036
921 PRODUCT PHYSICAL ISSUE 72 0.0036
922 PRODUCT PREPARATION ERROR 73 0.0035
923 IMPAIRED WORK ABILITY 75 0.0035
924 TREATMENT FAILURE 290 0.0035
925 ANGIOEDEMA 152 0.0034
926 ERECTILE DYSFUNCTION 88 0.0034
927 PAIN OF SKIN 91 0.0034
928 ADVERSE EVENT 311 0.0034
929 THERAPEUTIC RESPONSE DECREASED 204 0.0034
930 VAGINAL HAEMORRHAGE 146 0.0034
931 DISEASE RECURRENCE 160 0.0034
932 UNDERDOSE 244 0.0033
933 CRYING 121 0.0033
934 BONE DENSITY DECREASED 104 0.0033
935 THERAPEUTIC PRODUCT EFFECT DECREASED 148 0.0033
936 PSORIATIC ARTHROPATHY 133 0.0033
937 DRUG ADMINISTRATION ERROR 100 0.0033
938 ABNORMAL BEHAVIOUR 128 0.0032
939 INTENTIONAL OVERDOSE 206 0.0032
940 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 82 0.0032
941 ANAPHYLACTIC SHOCK 81 0.0031
942 DEVICE MALFUNCTION 220 0.0031
943 PRODUCT AVAILABILITY ISSUE 71 0.0031
944 IRRITABILITY 183 0.0030
945 DRUG DOSE OMISSION 501 0.0030
946 DEVICE ISSUE 265 0.0030
947 MOOD ALTERED 80 0.0029
948 AGGRESSION 145 0.0029
949 INCORRECT DOSE ADMINISTERED 660 0.0029
950 NEEDLE ISSUE 82 0.0028
951 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 199 0.0028
952 OVERDOSE 603 0.0028
953 MULTIPLE SCLEROSIS 133 0.0028
954 DRUG INEFFECTIVE 3641 0.0028
955 INJECTION SITE PRURITUS 182 0.0027
956 DEVICE USE ERROR 94 0.0027
957 MATERNAL EXPOSURE DURING PREGNANCY 238 0.0027
958 MULTIPLE SCLEROSIS RELAPSE 183 0.0027
959 DRUG EFFECT DECREASED 138 0.0026
960 PANCREATIC CARCINOMA 73 0.0025
961 EPILEPSY 75 0.0025
962 INJECTION SITE ERYTHEMA 304 0.0024
963 INJECTION SITE RASH 74 0.0024
964 EXTRA DOSE ADMINISTERED 97 0.0024
965 INJECTION SITE MASS 88 0.0024
966 INJECTION SITE HAEMORRHAGE 188 0.0024
967 SUICIDE ATTEMPT 142 0.0023
968 FOETAL EXPOSURE DURING PREGNANCY 187 0.0023
969 INJECTION SITE BRUISING 179 0.0022
970 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 122 0.0022
971 INJECTION SITE PAIN 674 0.0022
972 ANGER 72 0.0021
973 WITHDRAWAL SYNDROME 89 0.0021
974 BREAST CANCER 195 0.0021
975 PRODUCT QUALITY ISSUE 282 0.0021
976 DEVICE BREAKAGE 83 0.0020
977 EXPOSURE DURING PREGNANCY 127 0.0020
978 SUICIDAL IDEATION 187 0.0020
979 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 404 0.0020
980 PSORIASIS 247 0.0019
981 DERMATITIS ATOPIC 98 0.0019
982 SKIN IRRITATION 81 0.0018
983 INJECTION SITE SWELLING 134 0.0017
984 PRODUCT SUBSTITUTION ISSUE 95 0.0016
985 INJECTION SITE REACTION 111 0.0016
986 DRUG WITHDRAWAL SYNDROME 139 0.0016
987 SKIN BURNING SENSATION 97 0.0014
988 PROSTATE CANCER 108 0.0013
989 DEVICE DIFFICULT TO USE 87 0.0013
990 ACNE 99 0.0013
991 NO ADVERSE EVENT 225 0.0012
992 DRUG ABUSE 103 0.0012
993 DRUG DEPENDENCE 183 0.0011
994 ACCIDENTAL EXPOSURE TO PRODUCT 113 0.0011
995 PRODUCT STORAGE ERROR 76 0.0009